Related Experiment Video
Updated: Oct 15, 2026

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
Rotating Frame Spin-Lock Cardiac MRI Method at 9.4 T Can Characterize Diffuse Fibrosis in Progressing Hypertensive
Riku Kiviluoto1, Diana Törmä1, Ahmed Tawfek1
1A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Purpose:
This study aimed to investigate the applicability of rotating frame spin-lock continuous wave (CW) T1ρ and relaxation along a fictitious field with Rank 2 (RAFF2) methods complementary to native T1 and late gadolinium enhancement (LGE) for cardiac magnetic resonance imaging (CMRI) of diffuse fibrosis in mice with advancing hypertensive heart disease (HHD) and diastolic dysfunction.
Methods:
HHD was induced in mice with angiotensin II infusion for 28 days; sham operated were used as controls. Phenotype progression was assessed with echocardiography. Characterization of diffuse fibrosis was performed with CMRI. CW-T1ρ and RAFF2 were compared with native T1 and LGE acquired on Days 14 and 28 of the experiment. Regions of interest in CMRI relaxation time maps and Picrosirius red-stained histological cardiac sections were compared.
Results:
Diffuse fibrosis in the left ventricle was visible on Day 14 with TRAFF2 relaxation time maps in the HHD group with early diastolic impairment, and CW-T1ρ showed a slight increase. Both CW-T1ρ and TRAFF2 showed elevated values on Day 28 in HHD mice, whereas native T1 showed an increase only on Day 28. LGE showed no accumulation. The presence of diffuse fibrosis was verified with cardiac histology.
Conclusions:
Rotating frame spin-lock CW-T1ρ and RAFF2 are more sensitive to native T1 and LGE in the characterization of diffuse fibrosis in advancing HHD in mice, being an alternative for the imaging of fibrotic remodeling also in other cardiac pathologies.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Magnetic Resonance Imaging

